{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:57:55Z","timestamp":1790812675313,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12059-7","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T05:58:12Z","timestamp":1753509492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Lpp-OmpA-BtaE fusion protein causes a protective immune response against Brucella melitensis in mice"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9406-9667","authenticated-orcid":false,"given":"Maryam Borhan","family":"Nobari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2204-6267","authenticated-orcid":false,"given":"Mohamad Reza","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8425-665X","authenticated-orcid":false,"given":"Farzaneh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-8406","authenticated-orcid":false,"given":"Nour","family":"Amirmozafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4112-8962","authenticated-orcid":false,"given":"Abbas Akhavan","family":"Sepahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"12059_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.micinf.2011.08.012","volume":"14","author":"C Czibener","year":"2012","unstructured":"Czibener, C. & Ugalde, J. E. Identification of a unique gene cluster of Brucella spp. That mediates adhesion to host cells. Microbes Infect. 14, 79\u201385. https:\/\/doi.org\/10.1016\/j.micinf.2011.08.012 (2012).","journal-title":"Microbes Infect."},{"key":"12059_CR2","doi-asserted-by":"publisher","unstructured":"Huleatt, J. W. et al. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine26, 201\u2013214, (2008). https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.062","DOI":"10.1016\/j.vaccine.2007.10.062"},{"key":"12059_CR3","doi-asserted-by":"publisher","first-page":"015","DOI":"10.1186\/s12896-015-0194-0","volume":"15","author":"KM Bennett","year":"2015","unstructured":"Bennett, K. M. et al. Hybrid Flagellin as a T cell independent vaccine scaffold. BMC Biotechnol. 15, 015\u20130194.  (2015).","journal-title":"BMC Biotechnol."},{"key":"12059_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","volume":"7","author":"MP Franco","year":"2007","unstructured":"Franco, M. P., Mulder, M., Gilman, R. H. & Smits, H. L. Human brucellosis. Lancet Infect. Dis. 7, 775\u2013786. https:\/\/doi.org\/10.1016\/S1473-3099(07)70286-4 (2007).","journal-title":"Lancet Infect. Dis."},{"key":"12059_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","volume":"6","author":"G Pappas","year":"2006","unstructured":"Pappas, G., Papadimitriou, P., Akritidis, N., Christou, L. & Tsianos, E. V. The new global map of human brucellosis. Lancet Infect. Dis. 6, 91\u201399. https:\/\/doi.org\/10.1016\/S1473-3099(06)70382-6 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"12059_CR6","doi-asserted-by":"crossref","unstructured":"Moreno, E., Blasco, J. M. & Moriy\u00f3n, I. Facing the Human and Animal Brucellosis Conundrums: The Forgotten Lessons. Microorganisms10 (2022).","DOI":"10.3390\/microorganisms10050942"},{"key":"12059_CR7","doi-asserted-by":"publisher","unstructured":"Nikbakht, M. & Pakbin, B. Nikbakht brujeni, G. Evaluation of a new lymphocyte proliferation assay based on Cyclic voltammetry; an alternative method. Sci. Rep. 9 https:\/\/doi.org\/10.1038\/s41598-019-41171-8 (2019).","DOI":"10.1038\/s41598-019-41171-8"},{"key":"12059_CR8","doi-asserted-by":"publisher","unstructured":"Avila-Calderon, E. D., Lopez-Merino, A., Sriranganathan, N., Boyle, S. M. & Contreras-Rodriguez A. A history of the development of Brucella vaccines. Biomed. Res. Int. 743509, (2013). https:\/\/doi.org\/10.1155\/2013\/743509 (2013).","DOI":"10.1155\/2013\/743509"},{"key":"12059_CR9","doi-asserted-by":"publisher","unstructured":"Roca, I., Espinal, Vila-Farres, X. & Vila, J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned Pan-Drug-Resistant menace. Front. Microbiol. 3 (148). https:\/\/doi.org\/10.3389\/fmicb.2012.00148 (2012).","DOI":"10.3389\/fmicb.2012.00148"},{"key":"12059_CR10","doi-asserted-by":"publisher","unstructured":"Elbehiry, A. et al. The development of diagnostic and vaccine strategies for early detection and control of human brucellosis, particularly in endemic areas. Vaccines (Basel. 11 https:\/\/doi.org\/10.3390\/vaccines11030654 (2023).","DOI":"10.3390\/vaccines11030654"},{"key":"12059_CR11","doi-asserted-by":"publisher","unstructured":"Heidary, M. et al. Evaluation of brucellosis vaccines: A comprehensive review. Front. Vet. Sci. 9 https:\/\/doi.org\/10.3389\/fvets.2022.925773 (2022).","DOI":"10.3389\/fvets.2022.925773"},{"key":"12059_CR12","doi-asserted-by":"publisher","unstructured":"Darbandi, A. et al. Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review. Front. Vet. Sci. 9 https:\/\/doi.org\/10.3389\/fvets.2022.903890 (2022).","DOI":"10.3389\/fvets.2022.903890"},{"key":"12059_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.tim.2006.04.005","volume":"14","author":"D Linke","year":"2006","unstructured":"Linke, D., Riess, T., Autenrieth, I. B., Lupas, A. & Kempf, V. A. Trimeric autotransporter adhesins: variable structure, common function. Trends Microbiol. 14, 264\u2013270. https:\/\/doi.org\/10.1016\/j.tim.2006.04.005 (2006).","journal-title":"Trends Microbiol."},{"key":"12059_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-94-007-0940-9_9","volume":"715","author":"A Lyskowski","year":"2011","unstructured":"Lyskowski, A., Leo, J. C. & Goldman, A. Structure and biology of trimeric autotransporter adhesins. Adv. Exp. Med. Biol. 715, 143\u2013158. https:\/\/doi.org\/10.1007\/978-94-007-0940-9_9 (2011).","journal-title":"Adv. Exp. Med. Biol."},{"key":"12059_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tim.2005.03.004","volume":"13","author":"SE Cotter","year":"2005","unstructured":"Cotter, S. E., Surana, N. K. & St Geme, J. W. 3 Trimeric autotransporters: a distinct subfamily of autotransporter proteins. Trends Microbiol. 13, 199\u2013205. https:\/\/doi.org\/10.1016\/j.tim.2005.03.004 (2005).","journal-title":"Trends Microbiol."},{"key":"12059_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.chom.2009.05.011","volume":"5","author":"KA Kline","year":"2009","unstructured":"Kline, K. A., Falker, S., Dahlberg, S., Normark, S. & Henriques-Normark, B. Bacterial adhesins in host-microbe interactions. Cell. Host Microb.. 5, 580\u2013592. https:\/\/doi.org\/10.1016\/j.chom.2009.05.011 (2009).","journal-title":"Cell. Host Microbe"},{"key":"12059_CR17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/IAI.01241-12","volume":"81","author":"V Ruiz-Ranwez","year":"2013","unstructured":"Ruiz-Ranwez, V. et al. BtaE, an adhesin that belongs to the trimeric autotransporter family, is required for full virulence and defines a specific adhesive pole of Brucella suis. Infect. Immun. 81, 996\u20131007. https:\/\/doi.org\/10.1128\/IAI.01241-12 (2013).","journal-title":"Infect. Immun."},{"key":"12059_CR18","doi-asserted-by":"publisher","unstructured":"Munoz Gonzalez, F. et al. The BtaF Adhesin Is Necessary for Full Virulence During Respiratory Infection by Brucella suis and Is a Novel Immunogen for Nasal Vaccination Against Brucella Infection. Front Immunol.10, 1775, (2019). https:\/\/doi.org\/10.3389\/fimmu.2019.01775","DOI":"10.3389\/fimmu.2019.01775"},{"key":"12059_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nbt0197-29","volume":"15","author":"G Georgiou","year":"1997","unstructured":"Georgiou, G. et al. Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live Recombinant vaccines. Nat. Biotechnol. 15, 29\u201334. https:\/\/doi.org\/10.1038\/nbt0197-29 (1997).","journal-title":"Nat. Biotechnol."},{"key":"12059_CR20","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1128\/jb.187.6.2127-2137.2005","volume":"187","author":"BH Lower","year":"2005","unstructured":"Lower, B. H., Yongsunthon, R., Vellano, F. P., Lower, S. K. & 3rd & Simultaneous force and fluorescence measurements of a protein that forms a bond between a living bacterium and a solid surface. J. Bacteriol. 187, 2127\u20132137. https:\/\/doi.org\/10.1128\/jb.187.6.2127-2137.2005 (2005).","journal-title":"J. Bacteriol."},{"key":"12059_CR21","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1073\/pnas.89.7.2713","volume":"A89","author":"JA Francisco","year":"1992","unstructured":"Francisco, J. A., Earhart, C. F. & Georgiou, G. Transport and anchoring of beta-lactamase to the external surface of Escherichia coli. Proc. Natl. Acad. Sci. U S. A89, 2713\u20132717. https:\/\/doi.org\/10.1073\/pnas.89.7.2713 (1992).","journal-title":"Proc. Natl. Acad. Sci. U S"},{"key":"12059_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4161\/bioe.27461","volume":"5","author":"GL Huang","year":"2014","unstructured":"Huang, G. L., Anderson, T. D. & Clubb, R. T. Engineering microbial surfaces to degrade lignocellulosic biomass. Bioengineered 5, 96\u2013106. https:\/\/doi.org\/10.4161\/bioe.27461 (2014).","journal-title":"Bioengineered"},{"key":"12059_CR23","doi-asserted-by":"publisher","unstructured":"Jeiranikhameneh, M., Razavi, M. R., Irani, S., Siadat, S. D. & Oloomi, M. Designing novel construction for cell surface display of protein E on Escherichia coli using non-classical pathway based on Lpp-OmpA. AMB Express.. 7 https:\/\/doi.org\/10.1186\/s13568-017-0350-0 (2017).","DOI":"10.1186\/s13568-017-0350-0"},{"key":"12059_CR24","doi-asserted-by":"publisher","unstructured":"Park, K. S. et al. Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2. J. Nanobiotechnol. 21 https:\/\/doi.org\/10.1186\/s12951-023-01928-w (2023).","DOI":"10.1186\/s12951-023-01928-w"},{"key":"12059_CR25","doi-asserted-by":"publisher","unstructured":"Thapa, H. B., Muller, A. M., Camilli, A. & Schild, S. An intranasal vaccine based on outer membrane vesicles against SARS-CoV-2. Front. Microbiol. 12 (752739). https:\/\/doi.org\/10.3389\/fmicb.2021.752739 (2021).","DOI":"10.3389\/fmicb.2021.752739"},{"key":"12059_CR26","doi-asserted-by":"publisher","unstructured":"Nicchi, S. et al. Decorating the surface of Escherichia coli with bacterial lipoproteins: a comparative analysis of different display systems. Microb. Cell. Fact. 20 https:\/\/doi.org\/10.1186\/s12934-021-01528-z (2021).","DOI":"10.1186\/s12934-021-01528-z"},{"key":"12059_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00430-019-00649-y","volume":"209","author":"A Thibau","year":"2020","unstructured":"Thibau, A. et al. Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets. Med. Microbiol. Immunol. 209, 243\u2013263. https:\/\/doi.org\/10.1007\/s00430-019-00649-y (2020).","journal-title":"Med. Microbiol. Immunol."},{"key":"12059_CR28","doi-asserted-by":"publisher","unstructured":"Bhattacharya, D., Nowotny, J., Cao, R. & Cheng, J. 3Drefine: an interactive web server for efficient protein structure refinement. Nucl. Acids Res. 44 https:\/\/doi.org\/10.1093\/nar\/gkw336 (2016).","DOI":"10.1093\/nar\/gkw336"},{"key":"12059_CR29","doi-asserted-by":"publisher","unstructured":"Kim, D. E., Chivian, D. & Baker, D. Protein structure prediction and analysis using the Robetta server. Nucl. Acids Res. 32 https:\/\/doi.org\/10.1093\/nar\/gkh468 (2004).","DOI":"10.1093\/nar\/gkh468"},{"key":"12059_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/IAI.00994-09","volume":"78","author":"MA Durward","year":"2010","unstructured":"Durward, M. A., Harms, J., Magnani, D. M., Eskra, L. & Splitter, G. A. Discordant Brucella melitensis antigens yield cognate CD8\u2009+\u2009T cells in vivo. Infect. Immun. 78, 168\u2013176. https:\/\/doi.org\/10.1128\/IAI.00994-09 (2010).","journal-title":"Infect. Immun."},{"key":"12059_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/IAI.00796-13","volume":"82","author":"AP Cannella","year":"2014","unstructured":"Cannella, A. P. et al. Brucella melitensis T cell epitope recognition in humans with brucellosis in Peru. Infect. Immun. 82, 124\u2013131. https:\/\/doi.org\/10.1128\/IAI.00796-13 (2014).","journal-title":"Infect. Immun."},{"key":"12059_CR32","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.4049\/jimmunol.1502265","volume":"196","author":"D Hanot Mambres","year":"2016","unstructured":"Hanot Mambres, D. et al. Identification of immune effectors essential to the control of primary and secondary intranasal infection with Brucella melitensis in mice. J. Immunol. 196, 3780\u20133793. https:\/\/doi.org\/10.4049\/jimmunol.1502265 (2016).","journal-title":"J. Immunol."},{"key":"12059_CR33","doi-asserted-by":"publisher","unstructured":"Lieberman, L. A. Outer membrane vesicles: A bacterial-derived vaccination system. Front. Microbiol. 13 https:\/\/doi.org\/10.3389\/fmicb.2022.1029146 (2022).","DOI":"10.3389\/fmicb.2022.1029146"},{"key":"12059_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40259-023-00627-0","volume":"38","author":"F Micoli","year":"2024","unstructured":"Micoli, F., Adamo, R. & Nakakana, U. Outer membrane vesicle vaccine platforms. BioDrugs 38, 47\u201359. https:\/\/doi.org\/10.1007\/s40259-023-00627-0 (2024).","journal-title":"BioDrugs"},{"key":"12059_CR35","doi-asserted-by":"publisher","unstructured":"Weyant, K. B. et al. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens. Nat. Commun. 14 https:\/\/doi.org\/10.1038\/s41467-023-36101-2 (2023).","DOI":"10.1038\/s41467-023-36101-2"},{"key":"12059_CR36","doi-asserted-by":"publisher","unstructured":"Konig, E. et al. Multi-Antigen outer membrane vesicle engineering to develop polyvalent vaccines: the Staphylococcus aureus case. Front. Immunol. 12 (752168). https:\/\/doi.org\/10.3389\/fimmu.2021.752168 (2021).","DOI":"10.3389\/fimmu.2021.752168"},{"key":"12059_CR37","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.4049\/jimmunol.1302561","volume":"192","author":"MA Vitry","year":"2014","unstructured":"Vitry, M. A. et al. Humoral immunity and CD4\u2009+\u2009Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis. J. Immunol. 192, 3740\u20133752. https:\/\/doi.org\/10.4049\/jimmunol.1302561 (2014).","journal-title":"J. Immunol."},{"key":"12059_CR38","doi-asserted-by":"publisher","unstructured":"Mailybayeva, A. et al. Evaluation of duration of immunogenicity and protective efficacy of improved influenza viral Vector-Based Brucella abortus vaccine against Brucella melitensis infection in sheep and goats. Front. Vet. Sci. 7 https:\/\/doi.org\/10.3389\/fvets.2020.00058 (2020).","DOI":"10.3389\/fvets.2020.00058"},{"key":"12059_CR39","doi-asserted-by":"publisher","first-page":"e0186484","DOI":"10.1371\/journal.pone.0186484","volume":"12","author":"A Mailybayeva","year":"2017","unstructured":"Mailybayeva, A. et al. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats. PLoS One. 12, e0186484. https:\/\/doi.org\/10.1371\/journal.pone.0186484 (2017).","journal-title":"PLoS One"},{"key":"12059_CR40","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1128\/CDLI.12.12.1429-1436.2005","volume":"12","author":"N Sanakkayala","year":"2005","unstructured":"Sanakkayala, N. et al. Induction of antigen-specific Th1-type immune responses by gamma-irradiated Recombinant Brucella abortus RB51. Clin. Diagn. Lab. Immunol. 12, 1429\u20131436. https:\/\/doi.org\/10.1128\/CDLI.12.12.1429-1436.2005 (2005).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"12059_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/sji.12175","volume":"79","author":"PA Bretscher","year":"2014","unstructured":"Bretscher, P. A. On the mechanism determining the TH1\/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases. Scand. J. Immunol. 79, 361\u2013376. https:\/\/doi.org\/10.1111\/sji.12175 (2014).","journal-title":"Scand. J. Immunol."},{"key":"12059_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.micinf.2010.10.015","volume":"13","author":"P Skendros","year":"2011","unstructured":"Skendros, P., Pappas, G. & Boura, P. Cell-mediated immunity in human brucellosis. Microbes Infect. 13, 134\u2013142. https:\/\/doi.org\/10.1016\/j.micinf.2010.10.015 (2011).","journal-title":"Microbes Infect."},{"key":"12059_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","volume":"20","author":"A Billiau","year":"2009","unstructured":"Billiau, A. & Matthys, P. Interferon-gamma: a historical perspective. Cytokine Growth Factor. Rev. 20, 97\u2013113. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.02.004 (2009).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"12059_CR44","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas, J. & Hughes, C. C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731\u20132738. https:\/\/doi.org\/10.4049\/jimmunol.172.5.2731 (2004).","journal-title":"J. Immunol."},{"key":"12059_CR45","doi-asserted-by":"publisher","unstructured":"Vahed, M. et al. Molecular dynamics simulation and experimental study of the surface-display of SPA protein via Lpp-OmpA system for screening of IgG. AMB Express. 10 (161). https:\/\/doi.org\/10.1186\/s13568-020-01097-1 (2020).","DOI":"10.1186\/s13568-020-01097-1"},{"key":"12059_CR46","doi-asserted-by":"publisher","unstructured":"Ritchie, J. A., Rupper, A., Cardelli, J. A. & Bellaire, B. H. Host interferon-\u03b3 inducible protein contributes to Brucella survival. Front. Cell. Infect. Microbiol. 2 https:\/\/doi.org\/10.3389\/fcimb.2012.00055 (2012).","DOI":"10.3389\/fcimb.2012.00055"},{"key":"12059_CR47","doi-asserted-by":"publisher","unstructured":"Xu, G. et al. Dynamic Changes of Th1 Cytokines and the Clinical Significance of the IFN-\u03b3\/TNF-\u03b1 Ratio in Acute Brucellosis. Mediators Inflamm. 5869257, (2019). https:\/\/doi.org\/10.1155\/2019\/5869257 (2019).","DOI":"10.1155\/2019\/5869257"},{"key":"12059_CR48","doi-asserted-by":"publisher","first-page":"103390microorga","DOI":"10.3390\/microorganisms10071260","volume":"10","author":"JM Pellegrini","year":"2022","unstructured":"Pellegrini, J. M., Gorvel, J. P. & M\u00e9met, S. Immunosuppressive mechanisms in brucellosis in light of chronic bacterial diseases. Microorganisms 10, 103390microorganisms10071260 (2022).","journal-title":"Microorganisms"},{"key":"12059_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133\u2013146. https:\/\/doi.org\/10.1038\/nri1001 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"12059_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s1359-6101(03)00043-1","volume":"14","author":"WT Watford","year":"2003","unstructured":"Watford, W. T., Moriguchi, M., Morinobu, A. & O\u2019Shea, J. J. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor. Rev. 14, 361\u2013368. https:\/\/doi.org\/10.1016\/s1359-6101(03)00043-1 (2003).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"12059_CR51","doi-asserted-by":"publisher","unstructured":"Mitchell, R. E. et al. IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation. Sci. Rep. 7 https:\/\/doi.org\/10.1038\/s41598-017-11803-y (2017).","DOI":"10.1038\/s41598-017-11803-y"},{"key":"12059_CR52","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/09291016.2019.1613794","volume":"52","author":"BN Priyanka, Shringi","year":"2021","unstructured":"Priyanka, Shringi, B. N., Choudhary, O. P. & Kashyap, S. K. Cytokines in brucellosis: biological rhythm at the interface of innate and adaptive immunity. Biol. Rhythm Res. 52, 1031\u20131043. https:\/\/doi.org\/10.1080\/09291016.2019.1613794 (2021).","journal-title":"Biol. Rhythm Res."},{"key":"12059_CR53","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","volume":"180","author":"KN Couper","year":"2008","unstructured":"Couper, K. N., Blount, D. G. & Riley, E. M. IL-10: the master regulator of immunity to infection. J. Immunol. 180, 5771\u20135777. https:\/\/doi.org\/10.4049\/jimmunol.180.9.5771 (2008).","journal-title":"J. Immunol."},{"key":"12059_CR54","doi-asserted-by":"publisher","first-page":"959328","DOI":"10.3389\/fimmu.2022.959328","volume":"13","author":"L Stranahan","year":"2022","unstructured":"Stranahan, L. et al. Primary and memory immune responses against rough Brucella canis are less robust compared to smooth B. abortus and B. melitensis following intratracheal infection in mice. Front. Immunol. 13, 959328. https:\/\/doi.org\/10.3389\/fimmu.2022.959328 (2022).","journal-title":"Front. Immunol."},{"key":"12059_CR55","doi-asserted-by":"publisher","unstructured":"Vitry, M. A. et al. Crucial role of gamma interferon-producing CD4\u2009+\u2009Th1 cells but dispensable function of CD8\u2009+\u2009T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infection Immunity80, 4271\u20134280, (2012). https:\/\/doi.org\/10.1128\/IAI.00761-12","DOI":"10.1128\/IAI.00761-12"},{"key":"12059_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2006.10.003","volume":"243","author":"J Sathiyaseelan","year":"2006","unstructured":"Sathiyaseelan, J. et al. Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity. Cell. Immunol. 243, 1\u20139. https:\/\/doi.org\/10.1016\/j.cellimm.2006.10.003 (2006).","journal-title":"Cell. Immunol."},{"key":"12059_CR57","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1139\/cjm-2017-0179","volume":"63","author":"T Li","year":"2017","unstructured":"Li, T. et al. Brucella melitensis M5-90Deltabp26 as a potential live vaccine that allows for the distinction between natural infection and immunization. Can. J. Microbiol. 63, 719\u2013729. https:\/\/doi.org\/10.1139\/cjm-2017-0179 (2017).","journal-title":"Can. J. Microbiol."},{"key":"12059_CR58","doi-asserted-by":"publisher","unstructured":"Eze, M. O. et al. Effects of opsonization and gamma interferon on growth of Brucella melitensis 16\u00a0M in mouse peritoneal macrophages in vitro. Infection and Immun.68, 257\u2013263, (2000). https:\/\/doi.org\/10.1128\/IAI.68.1.257-263.2000","DOI":"10.1128\/IAI.68.1.257-263.2000"},{"key":"12059_CR59","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/s41467-021-22308-8","volume":"12","author":"K Cheng","year":"2021","unstructured":"Cheng, K. et al. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Nat. Commun. 12, 2041. https:\/\/doi.org\/10.1038\/s41467-021-22308-8 (2021).","journal-title":"Nat. Commun."},{"key":"12059_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0952-7915(00)00180-1","volume":"13","author":"C Th\u00e9ry","year":"2001","unstructured":"Th\u00e9ry, C. & Amigorena, S. The cell biology of antigen presentation in dendritic cells. Curr. Opin. Immunol. 13, 45\u201351. https:\/\/doi.org\/10.1016\/s0952-7915(00)00180-1 (2001).","journal-title":"Curr. Opin. Immunol."},{"key":"12059_CR61","doi-asserted-by":"publisher","unstructured":"Zanna, M. Y. et al. Review of dendritic cells, their role in clinical immunology, and distribution in various animal species. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22158044 (2021).","DOI":"10.3390\/ijms22158044"},{"key":"12059_CR62","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1128\/iai.01151-08","volume":"77","author":"KA Pasquevich","year":"2009","unstructured":"Pasquevich, K. A. et al. Immunization with Recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4\u2009+\u2009and CD8\u2009+\u2009T cells as well as systemic and oral protection against Brucella abortus infection. Infect. Immun. 77, 436\u2013445. https:\/\/doi.org\/10.1128\/iai.01151-08 (2009).","journal-title":"Infect. Immun."},{"key":"12059_CR63","doi-asserted-by":"publisher","unstructured":"Zhu, L. et al. Comparison of immune effects between Brucella Recombinant Omp10-Omp28-L7\/L12 proteins expressed in eukaryotic and prokaryotic systems. Front. Vet. Sci. 7 https:\/\/doi.org\/10.3389\/fvets.2020.00576 (2020).","DOI":"10.3389\/fvets.2020.00576"},{"key":"12059_CR64","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1128\/iai.62.11.5201-5204.1994","volume":"62","author":"SC Oliveira","year":"1994","unstructured":"Oliveira, S. C. & Splitter, G. A. Subcloning and expression of the Brucella abortus L7\/L12 ribosomal gene and T-lymphocyte recognition of the Recombinant protein. Infect. Immun. 62, 5201\u20135204. https:\/\/doi.org\/10.1128\/iai.62.11.5201-5204.1994 (1994).","journal-title":"Infect. Immun."},{"key":"12059_CR65","doi-asserted-by":"publisher","first-page":"8079","DOI":"10.1128\/iai.73.12.8079-8088.2005","volume":"73","author":"J Cassataro","year":"2005","unstructured":"Cassataro, J. et al. Vaccination with the Recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4\u2009+\u2009T helper 1 response that protects against Brucella melitensis infection. Infect. Immun. 73, 8079\u20138088. https:\/\/doi.org\/10.1128\/iai.73.12.8079-8088.2005 (2005).","journal-title":"Infect. Immun."},{"key":"12059_CR66","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","volume":"34","author":"SD Perkins","year":"2010","unstructured":"Perkins, S. D., Smither, S. J. & Atkins, H. S. Towards a Brucella vaccine for humans. FEMS Microbiol. Rev. 34, 379\u2013394. https:\/\/doi.org\/10.1111\/j.1574-6976.2010.00211.x (2010).","journal-title":"FEMS Microbiol. Rev."},{"key":"12059_CR67","doi-asserted-by":"publisher","first-page":"106573","DOI":"10.1016\/j.intimp.2020.106573","volume":"84","author":"M Golshani","year":"2020","unstructured":"Golshani, M. et al. Evaluation of Poly(I:C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice. Int. Immunopharmacol. 84, 106573. https:\/\/doi.org\/10.1016\/j.intimp.2020.106573 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"12059_CR68","doi-asserted-by":"crossref","unstructured":"Mohammadi, E. & Golchin, M. High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species. Compar. Immunol. Microbiol. Infect. Dis.70, 101470 (2020).","DOI":"10.1016\/j.cimid.2020.101470"},{"key":"12059_CR69","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/agriculture13112137","volume":"13","author":"A Naseer","year":"2023","unstructured":"Naseer, A., Mo, S., Olsen, S. C. & McCluskey, B. Brucella melitensis vaccines: A systematic review. Agriculture 13, 2137 (2023).","journal-title":"Agriculture"},{"key":"12059_CR70","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.xphs.2020.10.011","volume":"110","author":"ML Darriba","year":"2021","unstructured":"Darriba, M. L., Cerutti, M. L., Bruno, L., Cassataro, J. & Pasquevich, K. A. Stability studies of the vaccine adjuvant U-Omp19. J. Pharm. Sci. 110, 707\u2013718. https:\/\/doi.org\/10.1016\/j.xphs.2020.10.011 (2021).","journal-title":"J. Pharm. Sci."},{"key":"12059_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.molimm.2016.01.001","volume":"71","author":"G Tadepalli","year":"2016","unstructured":"Tadepalli, G., Singh, A. K., Balakrishna, K., Murali, H. S. & Batra, H. V. Immunogenicity and protective efficacy of Brucella abortus Recombinant protein cocktail (rOmp19\u2009+\u2009rP39) against B. abortus 544 and B. melitensis 16\u00a0M infection in murine model. Mol. Immunol. 71, 34\u201341. https:\/\/doi.org\/10.1016\/j.molimm.2016.01.001 (2016).","journal-title":"Mol. Immunol."},{"key":"12059_CR72","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4142\/jvs.2017.18.S1.281","volume":"18","author":"J Lalsiamthara","year":"2017","unstructured":"Lalsiamthara, J. & Lee, J. H. Development and trial of vaccines against Brucella. J. Vet. Sci. 18, 281\u2013290. https:\/\/doi.org\/10.4142\/jvs.2017.18.S1.281 (2017).","journal-title":"J. Vet. Sci."},{"key":"12059_CR73","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1128\/aem.02499-07","volume":"74","author":"Z Yang","year":"2008","unstructured":"Yang, Z., Liu, Q., Wang, Q. & Zhang, Y. Novel bacterial surface display systems based on outer membrane anchoring elements from the marine bacterium Vibrio anguillarum. Appl. Environ. Microbiol. 74, 4359\u20134365. https:\/\/doi.org\/10.1128\/aem.02499-07 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"12059_CR74","doi-asserted-by":"publisher","unstructured":"Y\u0131lmaz \u00c7olak, \u00c7. Bacterial membrane vesicles as a novel vaccine platform against SARS-CoV-2. Curr. Microbiol. 81 https:\/\/doi.org\/10.1007\/s00284-024-03846-y (2024).","DOI":"10.1007\/s00284-024-03846-y"},{"key":"12059_CR75","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3389\/fimmu.2019.01759","volume":"10","author":"R Lopez-Santiago","year":"2019","unstructured":"Lopez-Santiago, R., Sanchez-Argaez, A. B., De Alba-Nunez, L. G., Baltierra-Uribe, S. L. & Moreno-Lafont, M. C. Immune response to mucosal Brucella infection. Front. Immunol. 10, 1759. https:\/\/doi.org\/10.3389\/fimmu.2019.01759 (2019).","journal-title":"Front. Immunol."},{"key":"12059_CR76","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/s0035-9203(02)90119-7","volume":"96","author":"MC Moreno-Lafont","year":"2002","unstructured":"Moreno-Lafont, M. C. et al. Antigen-specific activation and proliferation of CD4\u2009+\u2009and CD8\u2009+\u2009T lymphocytes from brucellosis patients. Trans. R Soc. Trop. Med. Hyg. 96, 340\u2013347. https:\/\/doi.org\/10.1016\/s0035-9203(02)90119-7 (2002).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"key":"12059_CR77","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/icb.2016.5","volume":"94","author":"B Clapp","year":"2016","unstructured":"Clapp, B., Yang, X., Thornburg, T., Walters, N. & Pascual, D. W. Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge. Immunol. Cell. Biol. 94, 496\u2013508. https:\/\/doi.org\/10.1038\/icb.2016.5 (2016).","journal-title":"Immunol. Cell. Biol."},{"key":"12059_CR78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.actbio.2019.04.033","volume":"91","author":"STT Schetters","year":"2019","unstructured":"Schetters, S. T. T. et al. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8(+) T cells. Acta Biomater. 91, 248\u2013257. https:\/\/doi.org\/10.1016\/j.actbio.2019.04.033 (2019).","journal-title":"Acta Biomater."},{"key":"12059_CR79","doi-asserted-by":"publisher","unstructured":"Prior, J. et al. (ed, T.) Bacterial-Derived outer membrane vesicles are potent adjuvants that drive humoral and cellular immune responses. Pharmaceutics 13 https:\/\/doi.org\/10.3390\/pharmaceutics13020131 (2021).","DOI":"10.3390\/pharmaceutics13020131"},{"key":"12059_CR80","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/ni.3224","volume":"16","author":"BJ Laidlaw","year":"2015","unstructured":"Laidlaw, B. J. et al. Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells. Nat. Immunol. 16, 871\u2013879. https:\/\/doi.org\/10.1038\/ni.3224 (2015).","journal-title":"Nat. Immunol."},{"key":"12059_CR81","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/intimm\/dxm072","volume":"19","author":"JB Lee","year":"2007","unstructured":"Lee, J. B., Lee, K. A. & Chang, J. Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation. Int. Immunol. 19, 1039\u20131048. https:\/\/doi.org\/10.1093\/intimm\/dxm072 (2007).","journal-title":"Int. Immunol."},{"key":"12059_CR82","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","volume":"185","author":"P de Figueiredo","year":"2015","unstructured":"de Figueiredo, P., Ficht, T. A., Rice-Ficht, A., Rossetti, C. A. & Adams, L. G. Pathogenesis and immunobiology of brucellosis: review of Brucella\u2013Host interactions. Am. J. Pathol. 185, 1505\u20131517. https:\/\/doi.org\/10.1016\/j.ajpath.2015.03.003 (2015).","journal-title":"Am. J. Pathol."},{"key":"12059_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12223-019-00691-6","volume":"65","author":"ED Avila-Calder\u00f3n","year":"2020","unstructured":"Avila-Calder\u00f3n, E. D. et al. Dendritic cells and Brucella spp. Interaction: the Sentinel host and the stealthy pathogen. Folia Microbiol. 65, 1\u201316. https:\/\/doi.org\/10.1007\/s12223-019-00691-6 (2020).","journal-title":"Folia Microbiol."},{"key":"12059_CR84","doi-asserted-by":"publisher","first-page":"275","DOI":"10.14348\/molcells.2014.2374","volume":"37","author":"AC Labonte","year":"2014","unstructured":"Labonte, A. C., Tosello-Trampont, A. C. & Hahn, Y. S. The role of macrophage polarization in infectious and inflammatory diseases. Mol. Cells. 37, 275\u2013285. https:\/\/doi.org\/10.14348\/molcells.2014.2374 (2014).","journal-title":"Mol. Cells"},{"key":"12059_CR85","doi-asserted-by":"publisher","unstructured":"Chen, S. et al. Macrophages in immunoregulation and therapeutics. Signal. Transduct. Target.  https:\/\/doi.org\/10.1038\/s41392-023-01452-1 (2023).","DOI":"10.1038\/s41392-023-01452-1"},{"key":"12059_CR86","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev-virology-100114-055226","volume":"2","author":"EI Zuniga","year":"2015","unstructured":"Zuniga, E. I., Macal, M., Lewis, G. M. & Harker, J. A. Innate and adaptive immune regulation during chronic viral infections. Annual Rev. Virol. 2, 573\u2013597. https:\/\/doi.org\/10.1146\/annurev-virology-100114-055226 (2015).","journal-title":"Annual Rev. Virol."},{"key":"12059_CR87","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.2147\/idr.S341331","volume":"14","author":"Y Tang","year":"2021","unstructured":"Tang, Y. et al. Serum levels of seven general cytokines in acute brucellosis before and after treatment. Infect. Drug Resist. 14, 5501\u20135510. https:\/\/doi.org\/10.2147\/idr.S341331 (2021).","journal-title":"Infect. Drug Resist."},{"key":"12059_CR88","doi-asserted-by":"publisher","unstructured":"Zhang, F. et al. The immunogenicity of OMP31 peptides and its protection against Brucella melitensis infection in mice. Sci. Rep. 9 https:\/\/doi.org\/10.1038\/s41598-019-40084-w (2019).","DOI":"10.1038\/s41598-019-40084-w"},{"key":"12059_CR89","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1128\/IAI.71.4.2110-2119.2003","volume":"immunity71","author":"CM Fernandez-Prada","year":"2003","unstructured":"Fernandez-Prada, C. M. et al. Interactions between Brucella melitensis and human phagocytes: bacterial surface O-Polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis. Infect. And. immunity71, 2110\u20132119. https:\/\/doi.org\/10.1128\/IAI.71.4.2110-2119.2003 (2003).","journal-title":"Infect. And"},{"key":"12059_CR90","doi-asserted-by":"publisher","first-page":"e114410","DOI":"10.1371\/journal.pone.0114410","volume":"9","author":"M Garcia-Quintanilla","year":"2014","unstructured":"Garcia-Quintanilla, M., Pulido, M. R., Pachon, J. & McConnell, M. J. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection. PLoS One. 9, e114410. https:\/\/doi.org\/10.1371\/journal.pone.0114410 (2014).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12059-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:28:05Z","timestamp":1757294885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12059-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12059"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12059-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27210"}}